A carregar...
NEW STRATEGY FOR DRUG TREATMENT OF LUMINAL HER2-NEGATIVE METASTATIC BREAST CANCER
The article deals with the new oral target drug Palbociclib and its place in estrogen-receptor therapy, a positive HER2-negative metastatic breast cancer. Until recently, the consistent endocrine therapy was the primary treatment for the patients of this subgroup, as it significantly improved clinic...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Russo |
| Publicado em: |
Remedium Group LLC
2017-06-01
|
| Colecção: | Медицинский совет |
| Assuntos: | |
| Acesso em linha: | https://www.med-sovet.pro/jour/article/view/1884 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|